Trials / Completed
CompletedNCT04519788
AT-301 Nasal Spray in Healthy Adults
A Double-blinded, Randomised, and Placebo-controlled Safety Study of AT-301 Nasal Spray in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Atossa Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, placebo-controlled, ascending dose, multi-cohort study. The study will be conducted in 2 parts: a single ascending dose (SAD) part (Part 1) followed by a multiple ascending dose (MAD) part (Part 2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AT-301B | Nasal Spray |
| DRUG | AT-301A | Nasal Spray |
Timeline
- Start date
- 2020-08-07
- Primary completion
- 2020-12-08
- Completion
- 2021-01-12
- First posted
- 2020-08-20
- Last updated
- 2021-01-19
Locations
1 site across 1 country: Australia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04519788. Inclusion in this directory is not an endorsement.